Literature DB >> 15857577

14-3-3 proteins--an update.

Paulette Mhawech1.   

Abstract

14-3-3 is a highly conserved acidic protein family, composed of seven isoforms in mammals. 14-3-3 protein can interact with over 200 target proteins by phosphoserine-dependent and phosphoserine-independent manners. Little is known about the consequences of these interactions, and thus are the subjects of ongoing studies. 14-3-3 controls cell cycle, cell growth, differentiation, survival, apoptosis, migration and spreading. Recent studies have revealed new mechanisms and new functions of 14-3-3, giving us more insights on this fascinating and complex family of proteins. Of all the seven isoforms, 14-3-3sigma seems to be directly involved in human cancer. 14-3-3sigma itself is subject to regulation by p53 upon DNA damage and by epigenetic deregulation. Gene silencing of 14-3-3sigma by CpG methylation has been found in many human cancer types. This suggests that therapy-targeting 14-3-3sigma may be beneficial for future cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857577     DOI: 10.1038/sj.cr.7290291

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  101 in total

1.  Possible additional roles in mating for Ustilago maydis Rho1 and 14-3-3 homologues.

Authors:  Cau D Pham; Michael H Perlin
Journal:  Commun Integr Biol       Date:  2010-01

2.  CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.

Authors:  S M Pulukuri; J S Rao
Journal:  Oncogene       Date:  2006-06-19       Impact factor: 9.867

Review 3.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

4.  Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer.

Authors:  Vijayababu M Radhakrishnan; Taylor J Jensen; Haiyan Cui; Bernard W Futscher; Jesse D Martinez
Journal:  Genes Chromosomes Cancer       Date:  2011-07-13       Impact factor: 5.006

5.  Involvement of Stat3 in mouse brain development and sexual dimorphism: a proteomics approach.

Authors:  Fabio Di Domenico; Gabriella Casalena; Rukhsana Sultana; Jian Cai; William M Pierce; Marzia Perluigi; Chiara Cini; Alessandra Baracca; Giancarlo Solaini; Giorgio Lenaz; Jia Jia; Suzan Dziennis; Stephanie J Murphy; Nabil J Alkayed; D Allan Butterfield
Journal:  Brain Res       Date:  2010-09-25       Impact factor: 3.252

6.  Transdifferentiation of peripheral blood mononuclear cells into epithelial-like cells.

Authors:  Abelardo Medina; Ruhangiz T Kilani; Nicholas Carr; Erin Brown; Aziz Ghahary
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  Comparative proteome analysis of human adenocarcinoma.

Authors:  Gaoming Xiao; Qionghui Lu; Cui Li; Wenxiang Wang; Yuejun Chen; Zhiqiang Xiao
Journal:  Med Oncol       Date:  2009-04-21       Impact factor: 3.064

8.  Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.

Authors:  A K Tiwari; A C Need; F W Lohoff; C C Zai; N I Chowdhury; D J Müller; A Putkonen; E Repo-Tiihonen; T Hallikainen; A E Anil Yağcıoğlu; J Tiihonen; J L Kennedy; H Y Meltzer
Journal:  Mol Psychiatry       Date:  2013-06-11       Impact factor: 15.992

9.  14-3-3 isoforms bind directly exon B of the 5'-UTR of human surfactant protein A2 mRNA.

Authors:  Georgios T Noutsios; Paul Ghattas; Stephanie Bennett; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

10.  Overexpression of 14-3-3σ counteracts tumorigenicity by positively regulating p73 in vivo.

Authors:  Cuizhi Geng; Meixiang Sang; Ruiling Yang; Wei Gao; Tao Zhou; Shijie Wang
Journal:  Oncol Lett       Date:  2011-08-31       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.